| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
147,236 |
128,430 |
$760K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,983 |
2,883 |
$485K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,318 |
3,054 |
$321K |
| 90837 |
Psychotherapy, 53 minutes with patient |
615 |
330 |
$46K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,589 |
2,676 |
$43K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
393 |
286 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,104 |
884 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,502 |
1,184 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
215 |
162 |
$19K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
258 |
174 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,768 |
1,280 |
$18K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,229 |
751 |
$16K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
764 |
535 |
$14K |
| 0002A |
|
265 |
226 |
$13K |
| 0001A |
|
275 |
235 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
59 |
54 |
$5K |
| 96127 |
|
803 |
539 |
$5K |
| 96160 |
|
902 |
638 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
93 |
79 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
60 |
30 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
28 |
25 |
$1K |
| 99173 |
|
1,323 |
944 |
$1K |
| 99401 |
|
80 |
35 |
$1K |
| 90686 |
|
1,161 |
875 |
$1K |
| D0145 |
Oral evaluation for a patient under three years of age |
40 |
31 |
$1K |
| 92551 |
|
1,058 |
769 |
$1K |
| 0012A |
|
23 |
22 |
$1K |
| 0011A |
|
44 |
43 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
148 |
117 |
$1K |
| 0003A |
|
29 |
17 |
$845.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
17 |
13 |
$666.06 |
| D1206 |
Topical application of fluoride varnish |
39 |
30 |
$583.94 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
30 |
17 |
$537.94 |
| 81003 |
|
419 |
333 |
$414.33 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
38 |
25 |
$335.68 |
| 36415 |
Collection of venous blood by venipuncture |
144 |
97 |
$334.94 |
| 90734 |
|
45 |
31 |
$280.00 |
| 85018 |
|
282 |
243 |
$147.49 |
| 94760 |
|
202 |
128 |
$10.65 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
1,581 |
1,170 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
37 |
28 |
$0.00 |
| 91300 |
|
476 |
374 |
$0.00 |
| 90633 |
|
29 |
12 |
$0.00 |
| 90670 |
|
13 |
13 |
$0.00 |
| 36416 |
|
270 |
219 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
17 |
13 |
$0.00 |
| 99000 |
|
1,320 |
892 |
$0.00 |
| 90619 |
|
50 |
39 |
$0.00 |
| 91301 |
|
82 |
75 |
$0.00 |
| 86592 |
|
21 |
14 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
37 |
28 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
21 |
14 |
$0.00 |